DexCom, Inc.

DXCM

$66.03

Name : DexCom, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $25,894,010,880.00

EPSttm : 1.42

DexCom, Inc.

$66.03

0.50%

$0.33

Float Short %

3.4

Margin Of Safety %

Put/Call OI Ratio

0.84

EPS Next Q Diff

0.2

EPS Last/This Y

0.59

EPS This/Next Y

0.5

Price

66.03

Target Price

102.08

Analyst Recom

1.47

Performance Q

-22.2

Relative Volume

0.8

Beta

1.42

Ticker: DXCM

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	DXCM	78.02	0.97	0.77	150760
2025-09-09	DXCM	78.39	0.97	1.68	152401
2025-09-10	DXCM	75.98	0.97	0.24	152732
2025-09-11	DXCM	76	0.93	0.95	157324
2025-09-12	DXCM	76.24	0.92	0.74	158331
2025-09-15	DXCM	75.57	0.91	0.42	154954
2025-09-16	DXCM	76.56	0.90	0.34	156776
2025-09-17	DXCM	76.44	0.89623175831194	0.88559804719284	157355
2025-09-18	DXCM	75.78	0.92	0.87	181447
2025-09-22	DXCM	69.5	1.15	0.62	156316
2025-09-23	DXCM	68.23	1.08	1.04	163016
2025-09-24	DXCM	67.51	1.09	0.44	166479
2025-09-25	DXCM	68.32	1.07	0.67	167601
2025-09-26	DXCM	67.1	1.03	0.65	171546
2025-09-29	DXCM	66.45	1.11	1.33	159886
2025-09-30	DXCM	67.28	1.10	1.73	161889
2025-10-01	DXCM	66.07	1.10	1.37	164599
2025-10-02	DXCM	66.43	1.11	1.07	169997
2025-10-03	DXCM	66.97	0.90	0.44	190999
2025-10-06	DXCM	66.35	0.87	0.32	185763
2025-10-07	DXCM	66.01	0.84	0.33	196962
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	DXCM	78.00	25.7	172.3	2.05
2025-09-09	DXCM	78.38	25.7	209.0	2.05
2025-09-10	DXCM	75.99	25.7	172.7	2.05
2025-09-11	DXCM	76.00	25.8	203.7	2.05
2025-09-12	DXCM	76.23	25.8	207.1	2.05
2025-09-15	DXCM	75.53	25.8	194.8	2.05
2025-09-16	DXCM	76.55	25.8	217.1	2.05
2025-09-17	DXCM	76.43	25.8	202.5	2.05
2025-09-18	DXCM	75.78	25.8	195.2	2.05
2025-09-19	DXCM	67.43	25.8	91.7	2.05
2025-09-22	DXCM	69.51	25.8	235.1	2.05
2025-09-23	DXCM	68.22	25.8	185.1	2.05
2025-09-24	DXCM	67.50	25.9	193.5	2.05
2025-09-25	DXCM	68.30	25.9	216.1	2.05
2025-09-26	DXCM	67.10	25.9	186.1	2.05
2025-09-29	DXCM	66.46	25.9	194.3	2.05
2025-09-30	DXCM	67.29	26.2	216.7	2.05
2025-10-01	DXCM	66.11	26.2	186.1	2.05
2025-10-02	DXCM	66.39	26.2	208.8	2.05
2025-10-03	DXCM	67.07	26.3	213.7	2.05
2025-10-06	DXCM	66.36	26.3	202.8	2.05
2025-10-07	DXCM	66.03	26.3	198.8	2.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	DXCM	-2.39	0.40	2.56
2025-09-09	DXCM	-2.37	0.40	2.56
2025-09-10	DXCM	-2.37	0.40	2.56
2025-09-11	DXCM	-2.37	0.40	2.87
2025-09-12	DXCM	-2.25	0.40	2.87
2025-09-15	DXCM	-0.77	0.40	2.87
2025-09-16	DXCM	-0.77	0.40	2.87
2025-09-17	DXCM	-0.77	0.40	2.87
2025-09-18	DXCM	-0.77	0.40	2.87
2025-09-19	DXCM	-0.77	0.40	2.87
2025-09-22	DXCM	-0.77	0.42	2.87
2025-09-23	DXCM	-0.77	0.42	2.87
2025-09-24	DXCM	-0.77	0.42	2.87
2025-09-25	DXCM	-0.77	0.42	3.40
2025-09-26	DXCM	-0.77	0.42	3.40
2025-09-29	DXCM	-0.77	0.43	3.40
2025-09-30	DXCM	-0.77	0.43	3.40
2025-10-01	DXCM	-0.77	0.43	3.40
2025-10-02	DXCM	-0.77	0.43	3.40
2025-10-03	DXCM	-0.77	0.43	3.40
2025-10-06	DXCM	-0.77	0.45	3.40
2025-10-07	DXCM	-0.77	0.45	3.40
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.48

Avg. EPS Est. Current Quarter

0.57

Avg. EPS Est. Next Quarter

0.68

Insider Transactions

-0.77

Institutional Transactions

0.45

Beta

1.42

Average Sales Estimate Current Quarter

1178

Average Sales Estimate Next Quarter

1251

Fair Value

81.43

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-63.3

Target Price

102.08

P/E

46.23

Forward P/E

25.61

PEG

1.91

P/S

6.02

P/B

10.06

P/Free Cash Flow

45.36

EPS

1.43

Average EPS Est. Cur. Y

2.05

EPS Next Y. (Est.)

2.55

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.29

Relative Volume

0.8

Return on Equity vs Sector %

-3

Return on Equity vs Industry %

3.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

198.8

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 10200

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y